Product Information
LOSARTAN-HYDROCHLOROTHIAZIDE 100-25 MG TAB is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $0.0793 per EA under NDC 00093736898. Its NADAC has been published 671 times since Nov 28, 2013.
FDA first approved this application on Apr 6, 2010. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
25; 100 mg/1; mg/1
Manufacturer
Teva Pharmaceuticals USA Inc.NDC
00093736898
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUMApproval Type
Generic (ANDA)
FDA Application
ANDA077157FDA Approved
4/6/2010
TE Code
AB
On Market Since
4/6/2010
Pharmacological Classes
Price Statistics
The NADAC for LOSARTAN-HYDROCHLOROTHIAZIDE 100-25 MG TAB has been published 671 times since Nov 28, 2013, and over the history we have for it it has declined 34.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0793 per EA |
|---|---|
| All-time high | $0.2811 (May 11, 2022) |
| All-time low | $0.0771 (Jan 23, 2019) |
| 52-week high | $0.0876 |
| 52-week low | $0.0771 |
| Median price | $0.1112 |
| Average price | $0.1208 |
| Largest weekly change | +41.4% (Jan 29, 2020) |
| Weeks tracked | 671 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Teva Pharmaceuticals USA Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Losartan Potassium and Hydrochlorothiazide market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Angiotensin 2 Receptor Blocker class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of LOSARTAN-HYDROCHLOROTHIAZIDE 100-25 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for LOSARTAN-HYDROCHLOROTHIAZIDE 100-25 MG TAB, manufactured by Teva Pharmaceuticals USA Inc., is $0.0793 per EA (NDC 00093736898), effective Sep 30, 2026.
How has the price of LOSARTAN-HYDROCHLOROTHIAZIDE 100-25 MG TAB changed over time?
Over the history we have for it, the NADAC for LOSARTAN-HYDROCHLOROTHIAZIDE 100-25 MG TAB has declined 34.3%. It has been tracked across 671 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for LOSARTAN-HYDROCHLOROTHIAZIDE 100-25 MG TAB?
Since Nov 28, 2013, the NADAC for LOSARTAN-HYDROCHLOROTHIAZIDE 100-25 MG TAB has ranged from a low of $0.0771 (Jan 23, 2019) to a high of $0.2811 (May 11, 2022), with a median of $0.1112 per EA.
Are there cheaper alternatives to LOSARTAN-HYDROCHLOROTHIAZIDE 100-25 MG TAB?
5 manufacturers publish a NADAC-priced product with the same active ingredient and strength as LOSARTAN-HYDROCHLOROTHIAZIDE 100-25 MG TAB in a comparable dosage form, but none are currently priced below it.
Who manufactures LOSARTAN-HYDROCHLOROTHIAZIDE 100-25 MG TAB?
LOSARTAN-HYDROCHLOROTHIAZIDE 100-25 MG TAB (NDC 00093736898) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.